Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
News|Articles|May 6, 2022
Latest Advances in CGM Technology: A 5-question Quiz
Author(s)Sydney Jennings
Advertisement
Continous glucose monitors (CGMs) received a flurry of US Food and Drug Administration (FDA) appprovals in 2018. Since then, the
Take the 5-question quiz below to see what you know about key original CGM approvals and features and the innovations and advances that have been approved since.
1. Which of the following was the first FDA-approved CGM system to include a fully implantable sensor to detect glucose?
Advertisement
Related to this article
The FDA has approved insulin efsitora alfa-gobe (Onswik) for adults with type 2 diabetes.
New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
Finerenone wins FDA clearance for type 1 diabetes–related CKD, lowering albuminuria in FINE-ONE and opening a long-awaited treatment path.
The US FDA cleared a novel insulin patch pump that can be used for up to 3 days with an additional 12-hour grace period in persons with diabetes.
Tirzepatide gained an FDA cardiovascular indication after SURPASS-CVOT showed noninferiority to dulaglutide in high-risk adults.
FDA authorized Abbott’s Libre Duo 10 Day system, the first wearable device to continuously monitor both glucose and ketones.
Advertisement
Advertisement
Trending on Patient Care Online
1
Immunizing Against Pain and Fear: Rethinking the Vaccination Experience
2
9 Drugs Approved for Primary Care: Q3 2026
3
HIV Testing Before and During PrEP: Getting It Right
4
Switch to Oral Semaglutide Linked to 4.1% Weight Loss at 3 Months in New Study
5